xpansions.com
#99,319,876
Global Rankeez rank
Better than 1.2% of the 100,511,422 domains we track
Best rank recorded
#99,319,876
2026-11
Worst rank recorded
#99,332,841
2026-07
Tracked since
2026-07
4 monthly snapshots
Source breakdown
Rankeez combines several independent public rankings. Here's how xpansions.com scores in each:
| Source | Rank |
|---|
See how these sources are combined and cross-validated →
Ranking history
xpansions.com's rank across 4 monthly snapshots. ▲ improved by 12,965 since 2026-07
| Month | Rank |
|---|---|
| 2026-07 | #99,332,841 |
| 2026-08 | #99,325,523 |
| 2026-10 | #99,321,667 |
| 2026-11 | #99,319,876 |
JSON API
{
"xpansions.com": 99319876,
"history": {
"2026-07": 99332841,
"2026-08": 99325523,
"2026-10": 99321667,
"2026-11": 99319876
}
}
GET https://rankeez.com/api/xpansions.com.json · see API docs →
More about xpansions.com
xpansions.com — page content & similar sites →
XOLAIR (omalizumab) for subcutaneous use is a prescription treatment for moderate to severe persistent allergic asthma not controlled with ICS and chronic idiopathic urticaria (CIU) in appropriate patients. See full safety & Boxed Warning
xpansions.com — full site profile →
WHOIS, tech stack and extended traffic history for xpansions.com.